Startups Nasdaq Futures Rise similispharma@gmail.comAugust 13, 20260 StartupsBy Priya SharmaAugust 13, 20268 min read Key Takeaways Investors flock to CoreWeave Startups drive Nasdaq futures upward Funding surges…
Startups Nvidia Rival Cerebras Stock Plunges similispharma@gmail.comAugust 13, 20260 StartupsBy Arjun MehtaAugust 13, 20268 min read Key Takeaways Investors flee Cerebras stock Losses mount for Nvidia rival Cerebras faces…
Startups India Startup Boom similispharma@gmail.comAugust 5, 20260 StartupsBy Rohan DesaiAugust 5, 20267 min read Key Takeaways Investors flock to Indian startups, raising $10 billion in funding. Startups…
Startups Arm Holdings Stock Soars similispharma@gmail.comAugust 1, 20260 StartupsBy Kavita NairAugust 1, 20268 min read Key Takeaways Investors target Arm Holdings for its $2 billion potential Venture capital…
Startups India Startup Compliance Warning similispharma@gmail.comJuly 25, 20260 StartupsBy Kavita NairJuly 25, 20268 min read Key Takeaways Investors face hefty penalties for non-compliance Regulators impose massive fines on…
Entrepreneurship Intel Invests Big In India similispharma@gmail.comJuly 16, 20260 EntrepreneurshipBy Arjun MehtaJuly 16, 20266 min read Key Takeaways Investing $5.7 billion, Intel expands India presence Intel targets India's 10%…
Startups AI Spending Impacts US Inflation similispharma@gmail.comJuly 15, 20260 StartupsBy Kavita NairJuly 15, 20269 min read Key Takeaways Massive AI spending in Indian startups has triggered a surge in…
Startups Apple Sues OpenAI Over Secrets similispharma@gmail.comJuly 12, 20260 StartupsBy Rohan DesaiJuly 12, 20267 min read Key Takeaways Lawsuits escalate as Apple sues OpenAI Engineers allegedly stole sensitive info…
Startups Samsung Beats Apple similispharma@gmail.comJuly 10, 20260 StartupsBy Kavita NairJuly 10, 20267 min read Key Takeaways Investors dumped Samsung's stock despite 1,800% profit jump Profits surpassed Apple…
Startups Nasdaq Alternative Indian Stocks similispharma@gmail.comJuly 5, 20260 StartupsBy Rohan DesaiJuly 5, 20266 min read Key Takeaways Investors are flocking to Zomato Nasdaq-100 underperforms amid growth Goldman Sachs…